Skip to main content

Table 1 Baseline Demographics of Patients

From: Improved adherence with once-daily versus twice-daily dosing of mometasone furoate administered via a dry powder inhaler: a randomized open-label study

 

MF-DPI 400 μg QD PM

(n = 611)

MF-DPI 200 μg BID

(n = 622)

Mean age, y

50.9

50.2

Patients by age, n (%)

  

   12 to <18 y

21 (3)

22 (4)

   18 to <65 y

444 (73)

465 (75)

   ≥65 y

146 (24)

135 (22)

Sex

  

   Women/men

338/273

357/265

Race

  

   White/nonwhite

607/4

615/7

Mean body weight, kg

77.3

76.7

 

n = 599

n = 614

Mean duration of SAR, y

17.2

19.2

 

n = 238

n = 235

Mean duration of PAR, y

19.7

20.9

 

n = 163

n = 164

Mean duration of asthma, y

16.4

16.2

 

n = 611

n = 622

  1. BID = twice-daily; MF-DPI = mometasone furoate administered via a dry powder inhaler; PAR = perennial allergic rhinitis; QD PM = once-daily in the evening; SAR = seasonal allergic rhinitis.
Back to article page

BMC Pulmonary Medicine

ISSN: 1471-2466

Contact us